Every Hayes publication is developed by multidisciplinary teams of clinicians and scientists using rigorous methods grounded in internally recognized standards for systematic review and Health Technology Assessment. Learn more about these evidence resources and see sample titles below.
See below for some of our recent publications.
Focus of the Report: This health technology assessment focuses on the use of the BostonSight prosthetic replacement of the ocular surface ecosystem (PROSE) treatment for primary or secondary dry eye disease (DED) in adults and pediatric patients.
Technology Description: BostonSight PRO…
Optilume is drug-coated balloon indicated to treat patients with obstructive urinary symptoms associated with anterior urethral stricture. It is designed to be used in adult males with urethral strictures ≤ 3 cm in length.
If you have a Hayes login, click here to view the full report on the Knowledge Center.
Focus of Report: This report focuses on the use of the NightBalance sleep position trainer (SPT) system for treatment of positional obstructive sleep apnea (POSA).
Technology Description: The NightBalance consists of a palm-sized device that is worn across the chest using an adjustable…
This report evaluates the clinical utility of pharmacogenomic testing to inform the selection or dose of medications for individuals diagnosed with depression, bipolar disorder, schizophrenia spectrum or other psychotic disorder, or anxiety disorder to improve clinical outcomes.
Focus of the Report: The focus of this report is on allogeneic hematopoietic stem cell transplantation (HSCT) utilizing alternative human leukocyte antigen (HLA)-matched donor sources in pediatric patients with sickle cell disease (SCD) without an HLA-matched sibling donor (MSD).
Technology D…
Focus of the Report: This health technology assessment focuses on the efficacy and safety of the life under kinetic evolution (LUKE) arm (Mobius Bionics) for adults with upper extremity (or limb) amputation.
Technology Description: Developed by DEKA Research and Development Corporation…
Vosoritide is a longer-acting C-type natriuretic peptide (CNP) analog that modulates activity of the fibroblast growth factor receptor 3 (FGFR3) by inhibiting a signaling pathway that mediates its effects, thereby stimulating endochondrial growth, resulting in enhanced growth velocity. It is indicated to increase linear growth in pediatric patients aged ≥ 5 years with achondr…
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of intravascular lithotripsy (IVL) for treatment of calcified arteries in patients with peripheral artery disease (PAD).
Focus of the Report: This report focuses on the use of functional electrical stimulation (FES) for treatment of dropped foot in patients who have multiple sclerosis (MS). The goals of this therapy are to improve gait, walking speed, quality of life, and overall functional mobility.
Technology…